ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 185 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,106 | -3.9% | 2,557 | +50.6% | 0.00% | – |
Q2 2023 | $8,439 | +250.0% | 1,698 | +248.0% | 0.00% | – |
Q1 2023 | $2,411 | -88.5% | 488 | -85.3% | 0.00% | – |
Q4 2022 | $20,946 | -61.2% | 3,330 | -32.4% | 0.00% | – |
Q3 2022 | $54,000 | -14.3% | 4,923 | -10.1% | 0.00% | – |
Q2 2022 | $63,000 | +80.0% | 5,474 | +41.9% | 0.00% | – |
Q1 2022 | $35,000 | -16.7% | 3,858 | +35.5% | 0.00% | – |
Q4 2021 | $42,000 | +200.0% | 2,848 | +420.7% | 0.00% | – |
Q3 2021 | $14,000 | -94.8% | 547 | -94.7% | 0.00% | -100.0% |
Q2 2021 | $271,000 | -26.0% | 10,410 | +0.4% | 0.00% | 0.0% |
Q1 2021 | $366,000 | +5128.6% | 10,368 | +3390.9% | 0.00% | – |
Q4 2020 | $7,000 | +250.0% | 297 | +494.0% | 0.00% | – |
Q3 2020 | $2,000 | -33.3% | 50 | -31.5% | 0.00% | – |
Q2 2020 | $3,000 | +200.0% | 73 | +46.0% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 50 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 50 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | – | 50 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |